With nearly 30 years of life science experience, Mark ensures the most senior-level oversight and management for our strategic accounts and customer relationships for Quintiles Advisory Services.
Prior to joining Quintiles, Mark was a partner at Oliver Wyman and led the Health & Life Science practice, directing numerous efforts to drive strategic and operational benefit to customer in a variety of areas including: commercial operations, clinical development, business development and alliance management, post-merger integration and enabling functions such as finance and human resources. Mark has been published and quoted in many leading publications such as Forbes, PharmaVoice and Pharmaceutical Executive on topics ranging from the implications of Medicare Part D, global leadership challenges in pharma to the evolution of the pharmaceutical business model.
Mark holds an MBA from the Simon School of Business Administration at the University of Rochester and a BS in Mechanical Engineering from the University of Rochester. Mark is based in New York City